Drug Profile
CZ 48
Alternative Names: Camptothecin-20-O-Propionate Hydrate; CZ48Latest Information Update: 29 Dec 2021
Price :
$50
*
At a glance
- Originator Cao Pharmaceuticals; CHRISTUS Stehlin Foundation for Cancer Research
- Developer Cao Pharmaceuticals; University of Texas Health Science Center at San Antonio
- Class Antineoplastics; Camptothecins; Drug conjugates; Esters; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Lymphoma; Solid tumours
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for phase-I development in Lymphoma(Late-stage disease) in USA (PO, Capsule)
- 28 Oct 2019 No recent reports of development identified for phase-I development in Solid-tumours(Late-stage disease) in USA (PO, Capsule)
- 13 Oct 2017 Phase-I development is ongoing for Solid tumours and Lymphoma in USA (NCT02575638)